Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

NCT06069375 · clinicaltrials.gov ↗
PHASE2
Phase
SUSPENDED
Status
24
Enrollment
OTHER
Sponsor class

Stopped Study has been temporarily stopped until another study is completed. Data from the other study may inform changes to this study.

Conditions

Interventions

Sponsor

Jerry Vockley, MD, PhD

Collaborators